<DOC>
	<DOCNO>NCT01294007</DOCNO>
	<brief_summary>The purpose study evaluate rate quality fusion PureGen Osteoprogenitor Cell Allograft , compare autograft bone instrument posterolateral fusion ( PLF ) procedure .</brief_summary>
	<brief_title>Radiographic Analysis Using PureGen Versus Autologous Bone Posterolateral Fusion ( PLF )</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Symptomatic lumbar degenerative disc disease two contiguous level L1 S1 Subjects back and/or leg pain indicate posterior stabilization without decompression level posterolateral fusion ( PLF ) Unresponsive conservative treatment least 6 month Radiographic evidence primary diagnosis More 2 level require posterolateral fusion Spondylolisthesis great Grade I Prior fail fusion surgery lumbar level ( ) Systemic local infection disc cervical spine , past present Active systemic disease Osteoporosis , osteomalacia , metabolic bone disease would significantly inhibit bone healing Use bone graft , Bone Morphogenetic Protein ( BMP ) bone graft substitute addition place product specify BMI great 40 Use post operative Spinal Cord Stimulator ( SCS ) Known suspect history alcohol and/or drug abuse Involved pending litigation worker 's compensation relate spine Pregnant planning become pregnant course study Insulindependent diabetes mellitus Life expectancy less duration study Any significant psychological disturbance could impair consent process ability complete selfassessment questionnaire Undergoing chemotherapy radiation treatment , chronic use oral injected steroid prolong use nonsteroidal antiinflammatory drug . Known history hypersensitivity anaphylactic reaction dimethyl sulfoxide ( DMSO )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>